Last update 20 Aug 2025

HSK-44459

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HSK44459
Target
PDE4B
Action
inhibitors
Mechanism
PDE4B inhibitors(Phosphodiesterase 4B inhibitors)
Therapeutic Areas
Cardiovascular DiseasesCongenital DisordersEye Diseases+ [5]
Active Indication
Dermatitis, AtopicBehcet SyndromeIdiopathic Pulmonary Fibrosis+ [1]
Inactive Indication-
Originator Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
Active Organization
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.Shanghai Haisishengnuo Pharmaceutical Technology Co., LtdSichuan Haisco Pharmaceutical Co., Ltd.Sichuan Haisco Pharmaceutical Co., Ltd.
+ [1]
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

7
Clinical Trials associated with HSK-44459
NCT07070739
/ Not yet recruitingPhase 2
A Multicenter, Open-label Study to Evaluate the Long-term Safety and Efficacy of HSK44459 Tablets for the Treatment of Patients With Bechet's Disease
NCT06996912
/ RecruitingPhase 2
A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis
CTR20252011
/ CompletedPhase 1
HSK44459片在健康受试者中的安全性、耐受性、药代动力学的I期临床研究
[Translation] Phase I clinical study on the safety, tolerability and pharmacokinetics of HSK44459 tablets in healthy subjects
100 Clinical Results associated with HSK-44459
Login to view more data
100 Translational Medicine associated with HSK-44459
Login to view more data
100 Patents (Medical) associated with HSK-44459
Login to view more data
100 Deals associated with HSK-44459
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicPhase 2
China
Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
22 May 2025
Behcet SyndromePhase 2-
Haisco Pharmaceutical Group Co., Ltd.Haisco Pharmaceutical Group Co., Ltd.
24 Mar 2025
Idiopathic Pulmonary FibrosisPhase 2
China
Sichuan Haisco Pharmaceutical Co., Ltd.Sichuan Haisco Pharmaceutical Co., Ltd.
17 Jan 2025
PsoriasisIND Approval
China
Shanghai Haisishengnuo Pharmaceutical Technology Co., Ltd
11 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free